We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

264 hedge funds and large institutions have $591M invested in Editas Medicine in 2022 Q3 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 75 reducing their positions, and 28 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more first-time investments, than exits

New positions opened: 39 | Existing positions closed: 28

27% more call options, than puts

Call options by funds: $23.8M | Put options by funds: $18.6M

5% more capital invested

Capital invested by funds: $561M → $591M (+$30.3M)

3% more funds holding

Funds holding: 256 → 264 (+8)

1.05% more ownership

Funds ownership: 69.17% → 70.22% (+1%)

3% less repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 75

Holders
264
Holders Change
+8
Holders Change %
+3.13%
% of All Funds
4.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
39
Increased
73
Reduced
75
Closed
28
Calls
$23.8M
Puts
$18.6M
Net Calls
+$5.13M
Net Calls Change
+$6.09M

Top Buyers

Rank Fund Capital Flow
1
Millennium Management
Millennium Management
New York
+$27M
2
PHS
PFM Health Sciences
California
+$10.1M
3
Goldman Sachs
Goldman Sachs
New York
+$5.11M
4
Two Sigma Investments
Two Sigma Investments
New York
+$4.89M
5
Man Group
Man Group
United Kingdom
+$4.82M

Top Sellers

Rank Fund Capital Flow
1
State Street
State Street
Massachusetts
-$23.9M
2
WP
Woodline Partners
California
-$12M
3
NAMA
Nikko Asset Management Americas
New York
-$6.12M
4
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group
Japan
-$6.12M
5
Citadel Advisors
Citadel Advisors
Florida
-$5.65M
Name Holding Trade Value Shares
Change 		Change in
Stake
FFA
201
Fairfield Financial Advisors
Massachusetts
$6.67K – – –
TPCW
202
TD Private Client Wealth
New York
$6.58K +$3.63K +233 +76%
BHWM
203
Beaird Harris Wealth Management
Texas
$6K – – –
PVH
204
Psagot Value Holdings
Israel
$6K – – –
FHA
205
First Horizon Advisors
Tennessee
$5K -$125 -8 -2%
AA
206
Ancora Advisors
Ohio
$5K – – –
EWM
207
Endurance Wealth Management
Rhode Island
$5K – – –
First Manhattan
208
First Manhattan
New York
$5K – – –
HI
209
Harbour Investments
Wisconsin
$5K – – –
HNB
210
Huntington National Bank
Ohio
$5K – – –
MWM
211
Mascoma Wealth Management
New Hampshire
$5K – – –
WT
212
Washington Trust
Rhode Island
$5K – – –
AWM
213
Ameliora Wealth Management
Switzerland
$5K +$7.79K +500 New
SN
214
Sittner & Nelson
Oregon
$4K -$4.67K -300 -50%
GWM
215
Geneos Wealth Management
Colorado
$4K -$1.56K -100 -20%
BWP
216
Baldwin Wealth Partners
Massachusetts
$4K – – –
CTC
217
Central Trust Company
Missouri
$4K – – –
ICM
218
Islay Capital Management
Texas
$4K – – –
TWA
219
TCI Wealth Advisors
Arizona
$4K – – –
WT
220
Whittier Trust
California
$4K – – –
AIP
221
Almanack Investment Partners
Pennsylvania
$4K +$5.19K +333 New
CWM
222
CarsonAllaria Wealth Management
Illinois
$3K – – –
Carson Wealth (CWM LLC)
223
Carson Wealth (CWM LLC)
Nebraska
$3K – – –
HPC
224
HM Payson & Co
Maine
$3K – – –
HI
225
Hoey Investments
Pennsylvania
$3K – – –
7 8
9
10 11

EDIT Hedge Fund Activity: Q3 2022 in Review

264 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2022, worth a combined $591M — up 5.4% from $561M a quarter earlier.

Buyers outnumbered sellers: 39 funds opened new EDIT positions and 28 closed out — a net gain of 11 holders — while 73 added to existing stakes and 75 trimmed.

The largest buyer was Millennium Management, adding an estimated $27M. The largest seller was State Street, cutting an estimated $23.9M.

  • 264 institutional investors held Editas Medicine (EDIT) as of Q3 2022, up from 256 in Q2 2022.
  • Funds reported $591M of Editas Medicine stock for Q3 2022, up 5.4% quarter-over-quarter.
  • 39 funds opened new Editas Medicine positions in Q3 2022 and 28 closed out, a net change of +11 holders.
  • The largest Editas Medicine buyer in Q3 2022 was Millennium Management, an estimated $27M added.
  • The largest Editas Medicine seller in Q3 2022 was State Street, an estimated $23.9M sold.

Based on aggregated 13F filings for Q3 2022.